Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice

References

• Arai, T., et al., 2017. Type i neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice. Scientific reports, 7, 42959.
   PubMed Web of Science ®Google Scholar
• Britsch, S., 2007. The neuregulin-I/ErbB signalling system in development and disease. Advances in anatomy, embryology, and cell biology, 190, 1–65.
   PubMed Web of Science ®Google Scholar
• Caillaud, K., et al., 2016. Neuregulin 1 improves glucose tolerance in adult and old rats. Diabetes & metabolism, 42 (2), 96–104.
   PubMed Web of Science ®Google Scholar
• Carraway, K.L., and Burden, S.J., 1995. Neuregulins and their receptors. Current opinion in neurobiology, 5 (5), 606–612.
   PubMed Web of Science ®Google Scholar
• Carver, R.S., Mathew, P.M., and Russell, W.E., 1997. Hepatic expression of ErbB3 is repressed by insulin in a pathway sensitive to PI-3 kinase inhibitors. Endocrinology, 138 (12), 5195–5201.
   PubMed Web of Science ®Google Scholar
• Carver, R.S., et al., 1996. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. Journal of biological chemistry, 271 (23), 13491–13496.
   PubMed Web of Science ®Google Scholar
• Carver, R.S., et al., 2002. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology, 123 (6), 2017–2027.
   PubMed Web of Science ®Google Scholar
• Ennequin, G., et al., 2015. Neuregulin 1 improves glucose tolerance in db/db mice. PLoS one, 4 (7), 7–9.
   Google Scholar
• Gambarotta, G., et al., 2013. Neuregulin 1 role in schwann cell regulation and potential applications to promote peripheral nerve regeneration. International review of neurobiology, 108, 223–256.
   PubMed Web of Science ®Google Scholar
• Hemi, R., et al., 2002. Transactivation of ErbB2 and ErbB3 by tumor necrosis factor- and anisomycin leads to impaired insulin signalling through serine/threonine phosphorylation of IRS proteins. Journal of biological chemistry, 277 (11), 8961–8969.
   PubMed Web of Science ®Google Scholar
• Hemi, R., et al., 2011. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes, 60 (4), 1134–1145.
   PubMed Web of Science ®Google Scholar
• Horiuchi, K., et al., 2005. Evaluation of the contributions of ADAMs 9, 12, 15, 17 and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Developmental biology, 283 (2), 459–471.
   PubMed Web of Science ®Google Scholar
• Jiang, J.X., et al., 2013. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. Hepatology, 58 (4), 1339–1348.
   PubMed Web of Science ®Google Scholar
• Komposch, K., and Sibilia, M., 2015. EGFR signalling in liver diseases. International journal of molecular sciences, 17 (1), 30.
   Web of Science ®Google Scholar
• Liu, Y., et al., 2017. ERBB4 acts as a suppressor in the development of hepatocellular carcinoma. Carcinogenesis, 38 (4), 465–473.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2016. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection. Oncotarget, 7 (4), 4981–4992.
   PubMedGoogle Scholar
• López-Soldado, I., et al., 2016. Neuregulin improves response to glucose tolerance test in control and diabetic rats. American journal of physiology - endocrinology and metabolism, 310 (6), E440–E451.
   PubMed Web of Science ®Google Scholar
• Mei, L., and Nave, K.A., 2014. Neuregulin-ERBB signalling in the nervous system and neuropsychiatric diseases. Neuron, 83 (1), 27–49.
   PubMed Web of Science ®Google Scholar
• Odiete, O., Hill, M.F., and Sawyer, D.B., 2012. Neuregulin in cardiovascular development and disease. Circulation research, 111 (10), 1376–1385.
   PubMed Web of Science ®Google Scholar
• Plowman, G.D., et al., 1993. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature, 366 (6454), 473–475.
   PubMed Web of Science ®Google Scholar
• Rupert, C.E., and Coulombe, K.L.K., 2015. The roles of neuregulin-1 in Cardiac development, homeostasis, and disease. Biomarker insights, 10 (Suppl 1), 1–9.
   PubMedGoogle Scholar
• Samuel, V.T., and Shulman, G.I., 2016. The pathogenesis of insulin resistance: integrating signalling pathways and substrate flux. Journal of clinical investigation, 126 (1), 12–22.
   PubMed Web of Science ®Google Scholar
• Talmage, D.A., 2008. Mechanisms of neuregulin action. Novartis foundation symposium, 289, 74–84. discussion 84-93.
   PubMedGoogle Scholar
• Yarden, Y., and Sliwkowski, M.X., 2001. Untangling the ErbB signalling network. Nature reviews molecular cell biology, 2 (2), 127–137.
   PubMed Web of Science ®Google Scholar
• Zhang, P., et al., 2018. NRG1-Fc improves metabolic health via dual hepatic and central action. JCI insight, 3 (5), e98522.
   PubMed Web of Science ®Google Scholar